Relmada Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:RLMD) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -8.8 M-18.07 M-6.4 M-6.72 M-14.6 M -45.79 M Cash from investing activities 11.35 M15.36 M6.68 M6.75 M-76.93 M -48.14 M Cash from financing activities -172.49 K0-73.02 K093.64 M 93.56 M Free cash flow -8.8 M-18.07 M-6.4 M-6.72 M-14.6 M -45.79 M

뉴스

Does Relmada Therapeutics (RLMD) Have the Potential to Rally 75.58% as Wall Street Analysts Expect?

Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See (NASDAQ:RLMD)

Relmada Therapeutics, Inc. (RLMD) Q4 2025 Earnings Call Transcript

미주호, 렐마다 암 치료 데이터 긍정적...투자의견 ’매수’ 유지

Mizuho reiterates Relmada stock rating on positive cancer trial data

RLMD Stock Surges 42% in a Week: Here's What You Should Know

Avago, Lumentum among market cap stock movers on Monday

Tesla and Facebook among market cap stock movers on Monday

미주호, 방광암 임상 데이터에 렐마다 주식 등급 재확인

Mizuho reiterates Relmada stock rating on bladder cancer trial data

Hims & Hers shares soar premarket; Pfizer, Agilent Technologies slip

Hims & Hers 주가 장전 급등, 화이자와 Agilent Technologies 하락